Abstract
Depleted uranium results from the enrichment of natural uranium for energetic purpose. Its potential dispersion in the environment would set human populations at risk of being contaminated through ingestion. Uranium can build up in the brain and induce behavior disorders. As a major constituent of the myelin sheath, cholesterol is essential to brain function, and several neurological pathologies result from a disruption of cholesterol metabolism. To assess the effect of a chronic contamination with depleted uranium on cerebral cholesterol metabolism, rats were exposed to depleted uranium for 9 months through drinking water at 40 mg/l. The study focuses on gene expression. Cholesterol-catabolizing enzyme CYP46A1 displayed a 39% increase of its messenger RNA (mRNA) level. 3-Hydroxy-3-methylglutamyl CoA synthase gene expression rose from 91%. Concerning cholesterol transport, mRNA levels of scavenger receptor-B1 and adenosine triphosphate-binding cassette transporter A1 increased by 34% and that of apolipoprotein E by 75%. Concerning regulation, gene expression of nuclear receptors peroxisome proliferator-activated receptors α and γ increased by 46% and 36% respectively, whereas that of retinoid-X-receptor decreased by 29%. In conclusion, a chronic internal contamination with depleted uranium does not affect the health status of rats but induces molecular changes in the dynamic equilibrium of the cerebral cholesterol pool.
Abbreviations
- ABC (A1, A2, G1, G5):
-
adenosine triphosphate binding cassette transporter
- ACAT (1, 2):
-
acylCoenzymeA: cholesterol acyltransferase
- Apo E:
-
apolipoprotein E
- CYP:
-
cytochrome P450
- CYP46A1:
-
cholesterol 24-hydroxylase
- CYP7B1:
-
oxysterol 7alpha-hydroxylase
- CYP27A1:
-
sterol 27-hydroxylase
- CYP51:
-
lanosterol-14-hydroxylase
- DU:
-
depleted uranium
- HDL:
-
high-density lipoprotein
- HMGCoA (R/S):
-
3-hydroxy-3-methylglutaryl Coenzyme A Reductase/Synthase
- HNF (1α, 4α):
-
hepatocyte nuclear factor
- HPRT:
-
hypoxanthine-guanine phosphoribosyltransferase
- LDL:
-
low-density lipoprotein
- LDLr:
-
low-density lipoprotein receptor
- LXRβ:
-
liver-X-receptor β
- PPAR(α, γ):
-
peroxisome proliferator-activated receptor
- RXR:
-
retinoid-X-receptor
- SR-B1:
-
scavenger receptor class B type 1
- SREBP (1c, 2):
-
sterol regulatory element binding protein
References
Barber, D. S., Hancock, S. K., Mcnally, A. M., et al. (2007). Neurological effects of acute uranium exposure with and without stress. Neurotoxicology, 28, 1110–1119. doi:10.1016/j.neuro.2007.05.014.
Belles, M., Albina, M. L., Linares, V., Gomez, M., Sanchez, D. J., & Domingo, J. L. (2005). Combined action of uranium and stress in the rat. I. Behavioral effects. Toxicology Letters, 158, 176–185. doi:10.1016/j.toxlet.2005.03.011.
Bjorkhem, I. (2006). Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain. Journal of Internal Medicine, 260, 493–508. doi:10.1111/j.1365-2796.2006.01725.x.
Bjorkhem, I., & Leitersdorf, E. (2000). Sterol 27-hydroxylase deficiency: A rare cause of xanthomas in normocholesterolemic humans. Trends in Endocrinology and Metabolism, 11, 180–183. doi:10.1016/S1043-2760(00)00255-1.
Bjorkhem, I., & Meaney, S. (2004). Brain cholesterol: Long secret life behind a barrier. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 806–815. doi:10.1161/01.ATV.0000120374.59826.1b.
Briner, W., & Murray, J. (2005). Effects of short-term and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats. Neurotoxicology and Teratology, 27, 135–144. doi:10.1016/j.ntt.2004.09.001.
Brown 3rd, J., Theisler, C., Silberman, S., et al. (2004). Differential expression of cholesterol hydroxylases in Alzheimer’s disease. The Journal of Biological Chemistry, 279, 34674–34681. doi:10.1074/jbc.M402324200.
Bussy, C., Lestaevel, P., Dhieux, B., et al. (2006). Chronic ingestion of uranyl nitrate perturbs acetylcholinesterase activity and monoamine metabolism in male rat brain. Neurotoxicology, 27, 245–252. doi:10.1016/j.neuro.2005.11.003.
Castoldi, A. F., Coccini, T., Ceccatelli, S., & Manzo, L. (2001). Neurotoxicity and molecular effects of methylmercury. Brain Research Bulletin, 55, 197–203. doi:10.1016/S0361-9230(01)00458-0.
Cedazo-Minguez, A. (2007). Apolipoprotein E and Alzheimer’s disease: Molecular mechanisms and therapeutic opportunities. Journal of Cellular and Molecular Medicine, 11, 1227–1238.
Famer, D., Meaney, S., Mousavi, M., Nordberg, A., Bjorkhem, I., & Crisby, M. (2007). Regulation of alpha- and beta-secretase activity by oxysterols: Cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochemical and Biophysical Research Communications, 359, 46–50. doi:10.1016/j.bbrc.2007.05.033.
Finkelstein, Y., Markowitz, M. E., & Rosen, J. F. (1998). Low-level lead-induced neurotoxicity in children: An update on central nervous system effects. Brain Research. Brain Research Reviews, 27, 168–176. doi:10.1016/S0165-0173(98)00011-3.
Gilman, A. P., Villeneuve, D. C., Secours, V. E., et al. (1998). Uranyl nitrate: 28-day and 91-day toxicity studies in the Sprague–Dawley rat. Toxicological Sciences, 41, 117–128.
Goasguen, J., Lapresle, J., Ribot, C., & Rocquet, G. (1982). Intoxication par l’uranium metallique. Manifestations neurologiques chroniques. La Nouvelle Presse Medicale, 11, 119–121 Chronic neurological syndrome resulting from intoxication with metallic uranium (author’s transl).
Kathren, R. L., & Moore, R. H. (1986). Acute accidental inhalation of U: A 38-year follow-up. Health Physics, 51, 609–619. doi:10.1097/00004032-198611000-00004.
Mcdiarmid, M. A., Engelhardt, S., Oliver, M., et al. (2004). Health effects of depleted uranium on exposed Gulf War veterans: A 10-year follow-up. Journal of Toxicology and Environmental Health. Part A, 67, 277–296. doi:10.1080/15287390490273541.
Monleau, M., Bussy, C., Lestaevel, P., Houpert, P., Paquet, F., & Chazel, V. (2005). Bioaccumulation and behavioural effects of depleted uranium in rats exposed to repeated inhalations. Neuroscience Letters, 390, 31–36. doi:10.1016/j.neulet.2005.07.051.
Pellmar, T. C., Fuciarelli, A. F., Ejnik, J. W., et al. (1999a). Distribution of uranium in rats implanted with depleted uranium pellets. Toxicological Sciences, 49, 29–39. doi:10.1093/toxsci/49.1.29.
Pellmar, T. C., Keyser, D. O., Emery, C., & Hogan, J. B. (1999b). Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments. Neurotoxicology, 20, 785–792.
Pfrieger, F. W. (2003). Outsourcing in the brain: Do neurons depend on cholesterol delivery by astrocytes? BioEssays, 25, 72–78. doi:10.1002/bies.10195.
Ropenga, A., Chapel, A., Vandamme, M., & Griffiths, N. M. (2004). Use of reference gene expression in rat distal colon after radiation exposure: A caveat. Radiation Research, 161, 597–602. doi:10.1667/RR3173.
Shibata, S., Hayakawa, K., Egashira, Y., & Sanada, H. (2007). Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats. Life Sciences, 80, 546–553. doi:10.1016/j.lfs.2006.10.003.
Souidi, M., Gueguen, Y., Linard, C., et al. (2005). In vivo effects of chronic contamination with depleted uranium on CYP3A and associated nuclear receptors PXR and CAR in the rat. Toxicology, 214, 113–122. doi:10.1016/j.tox.2005.06.006.
Souidi, M., Tissandie, E., Grandcolas, L., et al. (2006). Chronic contamination with 137cesium in rat: Effect on liver cholesterol metabolism. International Journal of Toxicology, 25, 493–497. doi:10.1080/10915810600961317.
Su, T., & Waxman, D. J. (2004). Impact of dimethyl sulfoxide on expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes. Archives of Biochemistry and Biophysics, 424, 226–234. doi:10.1016/j.abb.2004.02.008.
Tissandie, E., Gueguen, Y., Lobaccaro, J. M., et al. (2007). In vivo effects of chronic contamination with depleted uranium on vitamin D3 metabolism in rat. Biochimica et Biophysica Acta, 1770, 266–272.
Vance, J. E., Karten, B., & Hayashi, H. (2006). Lipid dynamics in neurons. Biochemical Society Transactions, 34, 399–403. doi:10.1042/BST0340399.
Vaya, J., & Schipper, H. M. (2007). Oxysterols, cholesterol homeostasis, and Alzheimer disease. Journal of Neurochemistry, 102, 1727–1737. doi:10.1111/j.1471-4159.2007.04689.x.
Acknowledgments
The authors thank Dr Philippe Lestaevel for his helpful reading of the manuscript, as well as Cédric Baudelin, Thierry Loizeau, and Frédéric Voyer for animal care and contamination. This work is part of the ENVIRHOM research program supported by the Institute for Radiological Protection and Nuclear Safety (IRSN).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Racine, R., Gueguen, Y., Gourmelon, P. et al. Modifications of the Expression of Genes Involved in Cerebral Cholesterol Metabolism in the Rat Following Chronic Ingestion of Depleted Uranium. J Mol Neurosci 38, 159–165 (2009). https://doi.org/10.1007/s12031-008-9145-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9145-8